Astria Therapeutics

Forecast & Rating8 analysts currently cover Astria Therapeutics, with about 12.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $24.60, about 95.5% upside from the current price of $12.58. Price targets range from $13.00 to $49.00 — a wide spread, showing clear disagreement over just how much Astria Therapeutics can rise. For you, this means most institutions are cautious on Astria Therapeutics's outlook. Data as of Jan 23, 2026; for reference only and not investment advice.